Serum samples from Bulgarian patients with physician-diagnosed erythema migrans (EM) (n=105) were examined using Borrelia burgdorferi ELISA (Boehring, Germany) after previous absorption with Treponema phagedenis, For IgM antibody detection sera were additionally pretreated with anti-IgG serum (RF absorbent). Serum samples of 93 % of persons from healthy control group were IgM negative and all were IgG negative. Out of 105 patients with EM, 49 % were IgM positive and 14 % were borderline. IgG ELISA showed positive results for 17 % and borderline for 6 % of the patients. Positive and borderline serum samples were examined further by immunofluorescent assay (IFA) and immunoblot test with recombinant B, burgdorferi proteins from strain PKo (ll. ajzelii) -p100, flagellin, OspA and OspC, and internal flagellin fragments from strains PKo and PBi (B. gariniii [B.Wilske, V.Fingerle, P.Herzer et al. 1993. Med. Microbiol. Immunol, 182:255]. IFA detected IgM antibodies against B. burgdorferi in 47 % of the positive and in none of the borderline by IgM ELISA serum samples as well as IgG antibodies in 83 % of the positive and in 50% of the borderline by IgG ELISA samples. Presence of specific antibodies was confirmed by immunoblot in 71 % of the IgM ELISA postive and in 67 % of the IgG ELISA positive sera.
immunofluorescence assay (IFA) and the indirect enzyme-linked immunosorbent assay (ELISA). However, in early Lyme borreliosis when EM appears, serologic diagnosis is hampered by the limited humoral immune response restricted to small number of B. burgdorferi antigens. Crossreactivity wi th other microorganisms and falsepositive results for patients with autoimmune and viral diseases (5, 19, 28, 31) lead to low degree of test specificity. Therefore many laboratories perform immunoblotting as a confirmatory test. Imrnunoblotting allows to detect and analyze antibodies against individual B. burgdorferi proteins.
Interpretation of the immunoblot patterns is not standartized yet. Modification of the criteria of Dressler et al. (7) and Engstrom et al. (8) have been accepted in USA and a two-test protocol have been recommended for serologic diagnosis of Lyme borreliosis. Serum samples are first tested by a sensitive immunoassay and equivocal or positive samples are further to be analyzed by immunoblotting (2) . This approach was shown to contribute to higher sensitivity and specificity of the serologic testing for Lyme borreliosis (14, 16) . In Europe standartization of the immunoblots appears to be more difficult due to the greater B. burgdorferi strain heterogeneity.
In this report we present results from examination of sera from Bulgarian patients with physician-diagnosed EM. Serum samples were initially tested using an ELISA as ascreening test and were further analyzed by IFA and recombinant immunoblot. Based on major immunodominant proteins of the immune response in Lyme borreliosis, p l 00, the flagellin, OspA and OspC, the recombinant immunoblot avoids variable expression of B. burgdorferi proteins and the influence of cross-reactive proteins. We also evaluated serum reactivity to the major B. burgdorferi protein antigens in early Lyme borreliosis.
MATERIALS AND METHODS

Serum samples
Two group of serum samples were tested by ELISA and positive or equivocal samples were tested by IFA and immunoblot. Group I consisted of 90 serum samples collected from healthy blood donors with no history of Lyme disease. Group 2 consisted of serum samples from 105 Bulgarian patients with EM-lesions.
Detection of anti-B. burgdorferi antibodies by ELISA
Detection of IgM and IgG antibodies against B. burgdorferi was performed by ELISA according to the manufacturer's instructions (BoehringWerke AG, Magdeburg, Germany). Extracted antigen from German skin isolate PKo (B. afzelii), was coated on the microwells. Tested sera were absorbed with ultrasonicated Treponema phagedenis cells (2 mgl ml) to remove cross-reactive treponemal antibodies. For the IgM testing, sera were pretreated with anti-IgG serum (RF absorbent, BoehringWerke AG, Magdeburg, Germany). As it has been established, absorbance values above 0,500 for IgM results were positive and between 0,250 and 0,500 were borderline. For IgG results antibody units above 10 Vlml were determined as positive and between 5 and 10 Vlml as borderline.
Indirect immunofluorescence test IFA was performed as previously described (34) . Sera were pretreated with T. ph.agedenis ultrasonicate and for IgM test with RF absorbent as described for ELISA. As it was shown titers above I: 16 were considered posi ti ve (35) . reactive sera were found borderline and the other three were positive. All samples were negative by IFA and had no reactivity to any of the recombinant B. burgdorferi antigens by immunoblot. Serum reactivity to the recombinant B. burgdorferi antigens is presented in Fig.3 . IgM antibodies were directed mainly against OspC. In 42 (63,6%) of 66 serum samples OspC band was detected, followed by the reactivity to fIagelIin detected in 30 (45,5%) of 66 samples, internal flagellin fragment -in 6 (9,1 %) of 66 sera and p 100 -in 3 (4,5%) of 66. The major antigen for IgG antibodies was flagellin -21 (87,5%) of 24 samples, followed by p100 -9 (37,5%) of 24, internal flagellin fragment and OspC -3 (12,5%) of 24 samples.
Recombinant inununoblot
Comparison of the IFA-and recombinant irnrnunoblot-positive results revealed higher degree of coincidence in IgG than in IgM antibody detection. Out of 36 IgM immunoblot-positive results only 18 were also IFA-positive but all 12 IgG immunoblot-positive samples were at the same time IFA-positive.
DISCUSSION
The conventional serologic tests for Lyme borreliosis possess as a rule low specificity due to the cross-reactivity between B. burgdorferi and many other bacteria (5, 19 ). Preabsorbtion of the tested sera with T. phagedenis has been shown to increase the specificity of the tests (19, 34) eliminating the main part of the crossreactive antibodies. Another attempt to increase specificity is performing of a confirmatory immunoblot test. Wilske et al. (36, 37) showed the advantages of the recombinant immunoblot.
About 500 cases of Lyme borreliosis are reported annually in Bulgaria. Patients are mainly with erythema migrans, the clinical hallmark of early Lyme borreliosis. In this study, we analyzed sera from 105 Bulgarian patients with EM lesions.
Serum samples were previously absorbed with T. phagedenis and tested using ELISA, IFA and immunoblot with recombinant p I 00, flagellin, OspA, OspC and internal flagellin fragment (36) . IgM ELISA reactivity was detected in 62,9% of the samples (48,6% positive, 14,3% borderline). In addition, IgG antibodies were detected in 22,8% of the sera from EM patients. The results showed good discriminatory ability and sensitivity of the ELISA test, capable to detect specific antibodies in more than half of patients with early Lyme borreliosis despite the delayed humoral immune response.
Usually, by routine ELISA tests only 30% to 40% of patients with erythema migrans are seroreactive (18, 24) . Recently, Panelius et al. developed an ELISA with recombinant OspC antigens (24) and with recombinant flagellin A proteins (25) , derived from B. burgdorferi sensu stricto, B. afzelii and B. garinii. The authors detected IgM specific antibodies in only 30% of patients with erythema migrans by the recombinant OspC ELISA and recombinant flagellin ELISA was found even less sensitive for serodiagnosis of erythema migrans. In addition, false-positi vity due to cross-reacting antibodies in sera from patients with rheumatoid factor, syphilis, and Epstein-Barr virus infection was observed by the recombinant ELISA assays. Unlike these results, we found strong seroreactivity to recombinant OspC and flagellin.
Results from examination with IFA pointed out that the test was less sensitive than ELISA in detection of anti-B. burgdorferi antibodies. IFA was more suitable for detection ofIgG than of IgM antibodies as was shown by the higher coincidence of ELISA and IFA when IgG antibodies were to be detected.
According to the guidelines for serologic diagnosis of Lyme borreliosis in USA (2), we used ELISA as a first step ofa two-step protocol. The second step was immunoblotting of all samples that had at least minimal ELISAreactivity. The immunoblot used was based on antigens derived mainly from strain PKo (B. afzeliii. Immunoblot with strain PKo has been previously shown as the most sensitive and was recommended for immunoblot serodiagnosis of Lyme borreliosis throughout Europe (13) . The main advantage of the recombinant immunoblot is easier identification of diagnostic bands in comparison with the whole cell lysate immunoblot (38) (39) (40) (41) .
Johnson at al. (14) and Ledue et aI. (16) have shown increasing screening sensitivity of the serologic testing when borderline samples were analyzed by immunoblotting. We also found 9 of the 15 IgM ELISA-borderline samples and 3 of 6 IgG ELISA-borderline sera to be immunoblot positive. All these sera without further testing will be defined as negative. Immunoblottling has been reported to be more sensitive than ELISA in patients with EM (1).
Ourfindings support previous examinations with conventional blot that OspC and flagellin are the most reactive proteins in early immune response (7, 12, 24) and suggest that reactivity to a single recombinant OspC could be sufficient criterion to interpret IgM immunoblot as positive. Despite possible cross-reactivity, Hauser et al. (13) suggested even a strong p41 band (flageIlin) as sufficient for positive IgM immunoblot. Using this criterion we could found 6 extra seropositives (12%) out of 51 patients with erythema migrans showing seroreactivity solely to flagellin in the immunoblot.
Magnarelli et al. (21) reported higher sensitivity and specificity of ELISA with recombinant outer surface proteins: OspA, OspB, OspC, OspE, OspF, and flageIlin, in comparison with the whole-cell ELISA. According to our results, flagellin and 100 kDa antigen were the most promising antigens for the IgG antibody detection. Flagellin has been shown to has crossreacting epitopes with other bacteria (26,33) but also it is one of the most important B. burgdorferi antigens in eliciting the immune response. Truncated recombinant flagellin portions of the internal part of the molecule, used in this study, improves the specificity of the serologic testing (9, 20, 30, 36) . 100 kDa protein have been reported to be specific and sensitive antigen (5, 17) . We were unable to detect anti-OspA antibodies. Patients with Lyme disease rarely have detectable levels of antibodies to OspA during the first months of the infection. A discrepancy has been established between abundant OspA-and variable OspC-expression on cultured B. burgdorferi (4,10, II ,23,32) but weak OspA-and strong OspC-anti body response in early Lyme borreliosis. It has been shown that OspC is preferentially expressed in vivo in the first weeks after infection when at the same time OspA-expression diminishes (22) .
Results of a European multicenter study of immunoblotting for serodiagnosis of Lyme borreliosis showed variations in significance of different bands for different European laboratories (29) . As a result no single rule for interpretation of the immunoblots could be formulated but a panel ofEuropean rules that provides a framework for interpretation adapted to the local characteristics.
Therefore, to avoid low level of sensitivity, a mixture of recombinant major B. burgdorferi antigens should be used in serodiagnosis. Further examinations are necessary to reveal the role of all B. burgdorferi immunodominant protein antigens in humoral immune response ofpatients with Lyme borreliosis.
